Cargando…
AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression
SIMPLE SUMMARY: Previous studies have shown that AXL is a crucial protein that is activated in mesothelioma to cause growth and invasiveness. p53 is the tumor suppressor protein that is most frequently inactivated by mutations in human cancers, but these p53 inactivating mutations are not common in...
Autores principales: | Song, Wei, Wang, Hao, Lu, Minmin, Ni, Xinxin, Bahri, Nacef, Zhu, Shuihao, Chen, Limin, Wu, Yuehong, Qiu, Jieqiong, Fletcher, Jonathan A., Ou, Wen-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601862/ https://www.ncbi.nlm.nih.gov/pubmed/32992696 http://dx.doi.org/10.3390/cancers12102757 |
Ejemplares similares
-
YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways
por: Ou, Wen-Bin, et al.
Publicado: (2021) -
Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53
por: Ou, Wen-Bin, et al.
Publicado: (2016) -
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
por: Oien, Derek B., et al.
Publicado: (2018) -
Proteasome Inhibition Suppresses KIT-Independent Gastrointestinal Stromal Tumors Via Targeting Hippo/YAP/Cyclin D1 Signaling
por: Chen, Ting, et al.
Publicado: (2021) -
Axl contributes to efficient migration and invasion of melanoma cells
por: Shao, Hanshuang, et al.
Publicado: (2023)